Related Experiment Video
Updated: Jun 26, 2025
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Fate control engagement augments NK cell responses in LV/hu-IL-12 transduced sarcoma
Mary Jo Rademacher1, Mary L Faber1, Kathleen M Bone2
1Departments of Pediatrics; Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Introduction:
NK cells are an untapped resource for cancer therapy. Sarcomas transduced with lentiviruses to express human IL-12 are only cleared in mice bearing mature human NK cells. However, systemic inflammation limits IL-12 utilization. Fate control a.k.a. "suicide mechanisms" regulate unchecked systemic inflammation caused by cellular immunotherapies. Despite increasing utilization, there remains limited data on immune consequences or tumor-directed effects of fate control.
Objectives:
We sought to engage the mutant thymidylate kinase (mTMPK) metabolic fate control system to regulate systemic inflammation and assess the impact on NK cell effector functions.
Methods:
Primary human sarcoma short-passage samples and cell lines were transduced with LV/hu-IL-12_mTMPK engineering expression of IL-12 and an AZT-associated fate control enzyme. We assessed transduced sarcoma responses to AZT engagement and subsequent modulation of NK cell functions as measured by inflammatory cytokine production and cytotoxicity.
Results:
AZT administration to transduced (LV/hu-IL-12_mTMPK) short-passage primary human sarcomas and human Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma cell lines, abrogated the robust expression of human IL-12. Fate control activation elicited a specific dose-dependent cytotoxic effect measured by metabolic activity (WST-1) and cell death (Incucyte). NK effector functions of IFN-γ and cytotoxic granule release were significantly augmented despite IL-12 abrogation. This correlated with preferentially induced expression of NK cell activation ligands.
Conclusions:
mTMPK fate control engagement terminates transduced sarcoma IL-12 production and triggers cell death, but also augments an NK cell-mediated response coinciding with metabolic stress activating surface ligand induction. Fate control engagement could offer a novel immune activation method for NK cell-mediated cancer clearance.
Insights
Engaging mutant thymidylate kinase (mTMPK) fate control in sarcomas stops IL-12 production but enhances NK cell anti-cancer activity. This strategy could improve NK cell-mediated cancer clearance.
Area of Science:
- Immunology
- Cancer Therapy
- Cellular Engineering
Background:
- Natural killer (NK) cells are a promising cancer therapy resource.
- Interleukin-12 (IL-12) enhances NK cell activity but systemic inflammation limits its use.
- Fate control mechanisms are used to manage inflammation from cellular immunotherapies, but their immune effects are not well understood.
Purpose of the Study:
- To investigate the mutant thymidylate kinase (mTMPK) metabolic fate control system for regulating systemic inflammation.
- To assess the impact of mTMPK fate control on NK cell effector functions in sarcoma.
Main Methods:
- Human sarcoma samples and cell lines were engineered to express IL-12 and an AZT-dependent fate control enzyme (mTMPK).
- The response of engineered sarcomas to AZT was evaluated.
- NK cell functions, including inflammatory cytokine production and cytotoxicity, were measured following AZT engagement.
Main Results:
- AZT administration abrogated IL-12 expression in engineered sarcomas.
- Fate control activation induced dose-dependent sarcoma cell death.
- NK cell functions, including interferon-gamma (IFN-γ) production and cytotoxic granule release, were augmented.
- This augmentation correlated with increased expression of NK cell activation ligands.
Conclusions:
- mTMPK fate control effectively terminates IL-12 production in sarcomas and induces cell death.
- Fate control engagement augments NK cell-mediated responses by inducing surface ligand expression under metabolic stress.
- This approach presents a novel strategy for immune activation to enhance NK cell-mediated cancer clearance.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:28Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...